ENANTA PHARMACEUTICALS INC ENTA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-03-21
ENANTA PHARMACEUTICALS INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 1,847,519 | $24.0M |
| MILLENNIUM MANAGEMENT LLC | 882,097 | $11.1M |
| RENAISSANCE TECHNOLOGIES LLC | 665,258 | $8.4M |
| AQR CAPITAL MANAGEMENT LLC | 313,157 | $4.0M |
| CITADEL ADVISORS LLC | 293,233 | $3.7M |
| TWO SIGMA INVESTMENTS, LP | 267,364 | $3.4M |
| D. E. Shaw & Co., Inc. | 70,884 | $895,265 |
Source: SEC EDGAR filings · CIK 0001177648 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.